Huge win for Starpharma with A$5.5m R&D refund – groundbreaking drugs on the way?
Starpharma Holdings Limited, an Australian biotechnology company known for its work in dendrimer technology, has secured an AU$5.5 million Research and Development (R&D) Tax Incentive ... Read More